Clinical Trial

Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy

Study acronym: CP
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 8, 2023 (before its estimated February 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine the effects of Central Nervous System Stimulants, represented by Methylphenidate and Modafinil, compared to placebo control on motor performance in children with Cerebral Palsy. This study will be a triple-masked study per the American Academy of Neurology guidelines for clinical trials.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-12-21.
Trial Details
NCT Number NCT05675098
Lead Sponsor Kuwait University
Conditions Neurodevelopmental Disorders, Cerebral Palsy
Enrollment 30 participants
Start Date 2023-05-01
Primary Completion 2025-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2023-03-08